Pirovano M - Search Results

1

[The Treatment of Metastatic Renal Cell Carcinoma: An Update].

Pezzicoli G, Ganini C, Re Sartò GV, Pirovano M, Cosmai L, Porta C. Pezzicoli G, et al. Among authors: pirovano m. G Ital Nefrol. 2023 Oct 3;40(Suppl 81):2023-S81. G Ital Nefrol. 2023. PMID: 38007832 Review. Italian.

2

Letter to the Editor: Tumor Lysis Syndrome During Selpercatinib Treatment in a Patient with Medullary Thyroid Cancer.

De Leo S, Trevisan M, Re Sartò GV, Moneta C, Pirovano M, Colombo C, Cosmai L, Fugazzola L. De Leo S, et al. Among authors: pirovano m. Thyroid. 2023 Sep;33(9):1130-1132. doi: 10.1089/thy.2023.0214. Epub 2023 Aug 10. Thyroid. 2023. PMID: 37463111 No abstract available.

3

[Management of Chemotherapy in Patients Subjected in Chronic Dialysis Treatment].

Pirovano M, Re Sartò GV, Cosmai L. Pirovano M, et al. G Ital Nefrol. 2023 Oct 3;40(Suppl 81):2023-S81. G Ital Nefrol. 2023. PMID: 38007825 Review. Italian.

4

How to deal with renal toxicities from immune-based combination treatments in metastatic renal cell carcinoma. A nephrological consultation for Oncologists.

Tucci M, Cosmai L, Pirovano M, Campisi I, Re SGV, Porta C, Gallieni M, Piergiorgio M. Tucci M, et al. Among authors: pirovano m. Cancer Treat Rev. 2024 Apr;125:102692. doi: 10.1016/j.ctrv.2024.102692. Epub 2024 Jan 23. Cancer Treat Rev. 2024. PMID: 38492515 Review.

5

Osimertinib in a patient with end-stage kidney disease not on hemodialysis.

Pirovano M, Luciani A, Re Sartò GV, Bramati A, Cosmai L. Pirovano M, et al. J Nephrol. 2024 Jul 7. doi: 10.1007/s40620-024-02014-6. Online ahead of print. J Nephrol. 2024. PMID: 38972026

6

Acute Kidney Injury Associated with Anticancer Therapies: Small Molecules and Targeted Therapies.

Kala J, Joseph T, Pirovano M, Fenoglio R, Cosmai L. Kala J, et al. Among authors: pirovano m. Kidney360. 2024 Nov 1;5(11):1750-1762. doi: 10.34067/KID.0000000566. Epub 2024 Aug 26. Kidney360. 2024. PMID: 39186376 Free article. Review.

7

Management of cytotoxic chemotherapy in patients undergoing dialysis: a still unresolved issue of onconephrology.

Pirovano M, Ganini C, Gallieni M, Porta C, Cosmai L. Pirovano M, et al. J Nephrol. 2024 Oct 15. doi: 10.1007/s40620-024-02102-7. Online ahead of print. J Nephrol. 2024. PMID: 39404957 Review.

8

Post-Kidney Transplant Cancer: A Real-World Retrospective Analysis From a Single Italian Center.

Re Sartò GV, Alfieri C, Cosmai L, Brigati E, Campise M, Regalia A, Verdesca S, Molinari P, Pisacreta AM, Pirovano M, Nardelli L, Gallieni M, Castellano G. Re Sartò GV, et al. Among authors: pirovano m. Transpl Int. 2024 Aug 20;37:13220. doi: 10.3389/ti.2024.13220. eCollection 2024. Transpl Int. 2024. PMID: 39228659 Free PMC article.

9

IL-8 and its role as a potential biomarker of resistance to anti-angiogenic agents and immune checkpoint inhibitors in metastatic renal cell carcinoma.

Rizzo M, Varnier L, Pezzicoli G, Pirovano M, Cosmai L, Porta C. Rizzo M, et al. Among authors: pirovano m. Front Oncol. 2022 Aug 19;12:990568. doi: 10.3389/fonc.2022.990568. eCollection 2022. Front Oncol. 2022. PMID: 36059687 Free PMC article. Review.

10

Treatment of acute kidney injury in cancer patients.

Braet P, Sartò GVR, Pirovano M, Sprangers B, Cosmai L. Braet P, et al. Among authors: pirovano m. Clin Kidney J. 2021 Dec 24;15(5):873-884. doi: 10.1093/ckj/sfab292. eCollection 2022 May. Clin Kidney J. 2021. PMID: 35498895 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters